Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
112706074 | 11270607 | 4 | F | 20150706 | 20160704 | 20150714 | 20160710 | EXP | PHHY2015AU083388 | NOVARTIS | 74.17 | YR | M | Y | 0.00000 | 20160711 | CN | COUNTRY NOT SPECIFIED | AU |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
112706074 | 11270607 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, UNK | U | S0045 | 21008 | 20 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
112706074 | 11270607 | 1 | Carcinoid syndrome |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
112706074 | 11270607 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
112706074 | 11270607 | Abdominal pain | |
112706074 | 11270607 | Appendicitis perforated | |
112706074 | 11270607 | Dizziness | |
112706074 | 11270607 | Fatigue | |
112706074 | 11270607 | Hernia | |
112706074 | 11270607 | Pruritus | |
112706074 | 11270607 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
112706074 | 11270607 | 1 | 20140611 | 0 |